Home › Research › Health systems and care delivery
Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure
A.S. Chitnis, Rajender R. Aparasu, Hua Chen, Mark E. Kunik, Paul Ernest Schulz, Michael L. Johnson. American Journal of Alzheimer s Disease & Other Dementias®, 2015-12-24
Topic: Risk, prevention and care in population studies
Plain-language summary
Using the time-dependent Cox model, the adjusted dementia rate ratios (95% confidence-interval) among current and former users were 0.90(0.70-1.16) and 0.89 (0.71-1.10), respectively. Use of marginal structural model resulted in similar effect estimates for current and former users as compared with the nonusers. This study found no difference in risk of dementia among the current and former users of ACEI/ARB as compared with the nonusers in an already at-risk HF population.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. This study found no difference in dementia risk between users and non-users of ACE inhibitors or angiotensin receptor blockers in people with heart failure. It does not support these medications as a way to prevent dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chitnis, A., Aparasu, R. R., Chen, H., Kunik, M. E., Schulz, P. E., & Johnson, M. L. (2015). Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. American Journal of Alzheimer s Disease & Other Dementias®. https://doi.org/10.1177/1533317515618799
Vancouver
Chitnis A, Aparasu RR, Chen H, Kunik ME, Schulz PE, Johnson ML. Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. American Journal of Alzheimer s Disease & Other Dementias®. 2015. doi:10.1177/1533317515618799. PMID: 26705381.
BibTeX
@article{chitnis2015-26705381,
author = {Chitnis, A.S. and Aparasu, Rajender R. and Chen, Hua and Kunik, Mark E. and Schulz, Paul Ernest and Johnson, Michael L.},
title = {{Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure}},
journal = {American Journal of Alzheimer s Disease \& Other Dementias®},
year = {2015},
doi = {10.1177/1533317515618799},
pmid = {26705381},
url = {https://doi.org/10.1177/1533317515618799}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Using the time-dependent Cox model, the adjusted dementia rate ratios (95% confidence-interval) among current and former users were 0.90(0.70-1.16) and 0.89 (0.71-1.10), respectively.
- Use of marginal structural model resulted in similar effect estimates for current and former users as compared with the nonusers.
- This study found no difference in risk of dementia among the current and former users of ACEI/ARB as compared with the nonusers in an already at-risk HF population.
Why it matters
This study found no difference in dementia risk between users and non-users of ACE inhibitors or angiotensin receptor blockers in people with heart failure. It does not support these medications as a way to prevent dementia.
Study details
- Study designlongitudinal study
- Evidence strengthModerate
How this study scored 44/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (American Journal of Alzheimer s Disease & Other Dementias®) |
| Journal's citation record | 1 / 4 | American Journal of Alzheimer s Disease & Other Dementias®: journal h-index 93 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2015 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 11 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.8 citations a year over 13 year(s) since 2015 |
| Impact for its field and year | 1 / 6 | Cited 1.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Michael L. Johnson: h-index 70 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Baylor College of Medicine: institution h-index 1,607 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 26705381) |
| Free to read | 2 / 2 | Free to read |
| Total | 44 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Health systems and care delivery from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.